Copyright
©The Author(s) 2021.
World J Cardiol. Jan 26, 2021; 13(1): 11-20
Published online Jan 26, 2021. doi: 10.4330/wjc.v13.i1.11
Published online Jan 26, 2021. doi: 10.4330/wjc.v13.i1.11
95%CI | ||||
OR | Lower | Upper | P value | |
Age (yr) | ||||
18-65 | REF | REF | REF | REF |
> 65 | 1.02 | 1.02 | 1.02 | < 0.001 |
Hypertension | 0.56 | 0.50 | 0.62 | < 0.0001 |
Atrial fibrillation | 1.17 | 1.05 | 1.31 | 0.006 |
Tobacco abuse | 0.74 | 0.61 | 0.90 | 0.003 |
Hyperlipidemia | 0.69 | 0.61 | 0.78 | < 0.0001 |
Congestive heart failure | 1.34 | 1.22 | 1.48 | < 0.0001 |
Chronic liver disease | 1.51 | 1.19 | 1.92 | 0.001 |
Staphylococcus aureus | 1.25 | 1.13 | 1.39 | < 0.0001 |
Hemodialysis | 2.04 | 1.83 | 2.27 | < 0.0001 |
- Citation: Abe T, Eyituoyo HO, De Allie G, Olanipekun T, Effoe VS, Olaosebikan K, Mather P. Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus. World J Cardiol 2021; 13(1): 11-20
- URL: https://www.wjgnet.com/1949-8462/full/v13/i1/11.htm
- DOI: https://dx.doi.org/10.4330/wjc.v13.i1.11